ALFA Filings
Every announcement, straight from the exchange
Every Bajaj Healthcare earnings call announcement on NSE and BSE, newest first, each with its own page.
Time
3 announcements with these filters
Bajaj Healthcare delivered strong H1 growth led by a 82% surge in formulations and key new specialty launches.
Q1FY27 revenue grew 11.3% YoY to INR 165.6 Cr with PAT at INR 13.9 Cr. Focus shifting toward high-margin peptides, oncology APIs, and specialized formulations.
Bajaj Healthcare is pivoting from high-volume commodities to high-margin specialized APIs and formulations, targeting a ₹1000 Cr topline via new oncology and peptide capacities.